Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SCN1A | P35498 | 1/20 | 0.50 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.50 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.50 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22198592 | 0.90 | TSHR (0.53) | LMNATDP1MAPK1SLC6A2TSHR | |
| SCHEMBL11887308 | 0.90 | KDM4E (0.55) | LMNATDP1MAPK1HIF1AALDH1A1 | |
| SCHEMBL21113688 | 0.89 | TDP1 (0.70) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL12630627 | 0.88 | TDP1 (0.73) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL25339994 | 0.87 | LMNA (0.62) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL3400673 | 0.87 | LMNA (0.62) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL18522327 | 0.87 | MAPT (0.50) | LMNATDP1MAPK1HIF1ASLC6A2 | |
| SCHEMBL26622236 | 0.86 | TDP1 (0.71) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL17615513 | 0.86 | TDP1 (0.71) | LMNATDP1MAPK1HIF1ASLC6A3 | |
| SCHEMBL21104459 | 0.86 | LMNA (0.61) | LMNATDP1MAPK1HIF1ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3517555-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2024-11-27 | — | — | EP | claimed |
| EP-3517553-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2023-11-08 | — | — | EP | claimed |
| US-11325994-B2 | Catalyst component for olefin polymerization, catalyst, and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-05-10 | — | — | US | claimed |
| CN-107868147-B | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-107868149-B | Catalyst component for olefin polymerization, catalyst and application thereof | 中国石油化工股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| US-10662268-B2 | Catalyst component for olefin polymerization, catalyst, and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2020-05-26 | — | — | US | claimed |
| US-20190256623-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST, AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-08-22 | — | — | US | claimed |
| EP-3517555-A1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | China Petroleum&Chemical Corporation (CN) | 2019-07-31 | — | — | EP | claimed |
| EP-3517553-A1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | China Petroleum&Chemical Corporation (CN) | 2019-07-31 | — | — | EP | claimed |
| US-20190211119-A1 | CATALYST COMPONENT FOR OLEFIN POLYMERIZATION, CATALYST, AND USE THEREOF | BEIJING RESEARCH INSTITUTE OF CHEMICAL INDUSTRY, CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2019-07-11 | — | — | US | claimed |
| EP-3517555-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2024-11-27 | — | — | EP | disclosed |
| EP-3517553-B1 | CATALYST COMPONENT FOR USE IN OLEFIN POLYMERIZATION, CATALYST, AND APPLICATIONS THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2023-11-08 | — | — | EP | disclosed |
| US-11325994-B2 | Catalyst component for olefin polymerization, catalyst, and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2022-05-10 | — | — | US | disclosed |
| US-20210171688-A1 | BIOCOMPATIBLE COPOLYMER, CURABLE COMPOSITION, BIOCOMPATIBLE COATING LAYER AND BIOCOMPATIBLE DEVICE INCLUDING THE SAME | NATIONAL CENTRAL UNIVERSITY (TW) | 2021-06-10 | — | — | US | disclosed |
| US-10815228-B2 | Aztreonam derivatives and uses thereof | ARIXA PHARMACEUTICALS, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| US-20070185155-A1 | Muscarinic acetylcholine receptor antagonists | GLAXO GROUP LIMITED (GB) | 2007-08-09 | — | — | US | disclosed |
| US-20070179100-A1 | Protected monomers | ALNYLAM PHARMACEUTICALS, INC. | 2007-08-02 | — | — | US | disclosed |
| US-6505942-B2 | Anti-reflection material, polarization film, and production methods therefor | TOMOEGAWA PAPER CO., LTD. (JP) | 2003-01-14 | — | — | US | disclosed |
| US-20020034008-A1 | Anti-reflection material, polarization film, and production methods therefor | TOMOEGAWA PAPER CO., LTD. (JP) | 2002-03-21 | — | — | US | disclosed |
| US-6191884-B1 | COATING CONDUCTIVE MATERIALS INCLUDING INDIUM TIN OXIDE POWDER AND RESIN | TOMOEGAWA PAPER CO., LTD. (JP) | 2001-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10815228-B2 | Aztreonam derivatives and uses thereof | MGAM, ABCG2, SI | LMNA 2449/4885TDP1 2196/4885MAPK1 4720/4885 |
| US-20070179100-A1 | Protected monomers | PCNA, POLN, PARP1 | LMNA 111/4885TDP1 263/4885MAPK1 4090/4885 |
| US-20070185155-A1 | Muscarinic acetylcholine receptor antagonists | CHRM3, CHRNG, CHRM2 | LMNA 4137/4885TDP1 3416/4885MAPK1 4667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.